Conference abstract · 22 Aug 2016
Research articlePublished 2013
Etanercept Patient Assistance Program: Another Data Source for Epidemiological Studies?
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Patient assistance programs (PAP) have been established for biologic disease modifying therapies such as etanercept to improve patient knowledge and compliance and provide a means for follow-up. The information collected through these programs is a potential data source to determine patient characteristics, patient outcomes, treatment adherence and reimbursement practices of individuals prescribed biologic disease modifying therapies. Objective: To describe the population enrolled in the Enliven® Services Patient Assistance Program and to determine one-year retention rates. Methods: A retrospective review of a Canadian cohort of patients enrolled in an etanercept PAP diagnosed with rheumatoid arthritis (RA) was conducted. Demographic and utilization information was collected for all subjects enrolled in the period between 2000 and 2007. One-year retention rates were also calculated from the data collected. Descriptive statistics were used to characterize the data. Results: 14,335 subjects prescribed etanercept were enrolled in Enliven®. Average age at time of enrollment was 53 years. Three-quarters of subjects were female and four-fifths were English speaking. The largest percentage Conclusion: The analysis provides a snapshot of individuals administered etanercept therapy over a 7-year timeframe. PAPs are a valuable source of data for research on biological therapies in addition to the support provided to the patients.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 15 May 2021
Evaluation of health care delivery, safety procedures, and canine welfare in an inpatient Animal-Assisted Therapy (AAT) program: A multicenter Failure Modes and Effects Analysis (FMEA)
Conference abstract · 22 Aug 2016
Consumer acceptance of mobile-assisted smoking cessation programs
Conference abstract · 2020
Generation of a 3D printed brain model from MRI scan data to assist in Brain Surgery (using open source tools)
Research article · 3 May 2019
Plant Source of Egyptian Propolis Using Multivariate-assisted Digitally-enhanced TLC Data Analysis
More from this journal
The newest in Advances in Pharmacoepidemiology and Drug Safety.
Article · 10 Sep 2026
Periodic Safety Update Reports as an Essential Component of Continuous Drug Safety Monitoring
Article · 19 Dec 2025
Diabetes Medication Safety: Promoting Effective Glycemic Control Through Careful Therapeutic Management
Article · 19 Dec 2025
Drug Overdose Prevention: Strategies for Safe Medication Use and Public Health Protection
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAdvances in Pharmacoepidemiology and Drug Safety
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Brian C Chan”
- BylineArticles whose byline prints “Soo Jin Seung”
- BylineArticles whose byline prints “David McLean”
- BylineArticles whose byline prints “Mary Bell”
- BylineArticles whose byline prints “Neil H Shear”
- BylineArticles whose byline prints “Nicole Mittmann”

